This page shows the latest evolucumab news and features for those working in and with pharma, biotech and healthcare.
Looks to boost sales after trial shows clear clinical advantage of PCSK9 inhibitor over statins
But gives GlaxoSmithKline’s asthma drug Nucala the green light. The Scottish Medicines Consortium (SMC) has turned down Amgen's cholesterol-lowering treatment Repatha (evolucumab), citing a lack of “robust” data.
drug. The scheme includes an undisclosed discount to the NHS and allows NICE to back Praluent and Amgen's rival Repatha (evolucumab), which had already agreed a price cut, in new
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...